Fresenius Medical Care to take €110 mln charge in Q3 on China portfolio overhaul

By Reuters News

- Fresenius Medical Care FMEG.DE expects to book around €110 million ($127 million) in one-time charges in the third quarter related to changes to its China business, the German dialysis provider said on Friday.

The charges are mainly related to impairments, inventory scrappage and termination costs linked to the exit of its China peritoneal dialysis business and the discontinuation of its 4008A dialysis system.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.